William G. Harris - 26 Aug 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role: Director
Signature: /s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol: SLNO
Transactions as of: 26 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Oct 2022, 18:44:52 UTC
Previous filing: 14 Oct 2022
Next filing: 26 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SLNO	Common Stock						8,901	26 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SLNO	Stock option (right to buy)						93	26 Aug 2022	Common Stock	93	$535.50	Direct	F2, F3
holding	SLNO	Stock option (right to buy)						66	26 Aug 2022	Common Stock	66	$135.00	Direct	F2, F3
holding	SLNO	Stock option (right to buy)						66	26 Aug 2022	Common Stock	66	$349.50	Direct	F2, F3
holding	SLNO	Stock option (right to buy)						361	26 Aug 2022	Common Stock	361	$90.00	Direct	F2, F3
holding	SLNO	Stock option (right to buy)						601	26 Aug 2022	Common Stock	601	$54.00	Direct	F2, F3
holding	SLNO	Stock option (right to buy)						1,062	26 Aug 2022	Common Stock	1,062	$30.60	Direct	F3, F4
holding	SLNO	Stock option (right to buy)						823	26 Aug 2022	Common Stock	823	$39.45	Direct	F3, F4
holding	SLNO	Stock option (right to buy)						635	26 Aug 2022	Common Stock	635	$51.15	Direct	F3, F4
holding	SLNO	Stock option (right to buy)						2,666	26 Aug 2022	Common Stock	2,666	$33.60	Direct	F3, F4
holding	SLNO	Stock option (right to buy)						2,124	26 Aug 2022	Common Stock	2,124	$15.30	Direct	F3, F4
holding	SLNO	Stock option (right to buy)						2,666	26 Aug 2022	Common Stock	2,666	$2.55	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares beneficially owned reflects the 1-for-15 reverse stock split effected August 26, 2022.
F2	The per share exercise price and number of shares subject to the option reflect the 1-for-5 reverse stock split effected October 15, 2017 and the 1-for-15 reverse stock split effected August 26, 2022.
F3	All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F4	The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022.
F5	The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date.